Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05916495Not ApplicableCompleted

An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant

Role: collaborator

NCT06702228Recruiting

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland

Role: collaborator

NCT05662124Not ApplicableActive Not Recruiting

ILD: Health Outcomes in Remote Digital Monitoring Versus Usual Care

Role: collaborator

NCT05735288Completed

Haemodialysis Outcomes & Patient Empowerment Study 03

Role: collaborator

NCT03744598Terminated

Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis

Role: lead

NCT04850521Completed

Remote Monitoring of Interstitial Lung Disease

Role: lead

NCT04623281Completed

Haemodialysis Outcomes & Patient Empowerment Study 02

Role: collaborator

NCT03403491Not ApplicableCompleted

Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis

Role: lead

NCT03104322Not ApplicableCompleted

Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis

Role: lead

All 9 trials loaded